Skip to content
NYSE: IGC
|
Borse Berlin: IGS1.BE
|
Frankfurt: IGS1
IGC
India Globalization Capital Inc.
Menu
Home
Life Sciences
Infrastructure Business
Investors
Press Releases
SEC Filings
XBRL Files
Leadership
Governance
Letter to Our Stockholders
IGC Radica Patente para la Fórmula Hyalolex
April 10, 2018
September 10, 2019
by
charlie
Post navigation
← IGC Files Patent for Hyalolex Formulation
IGC Announces Financial Results for Fiscal Year Ended March 31, 2018 →